John Steitz - Innophos Holdings Independent Director

Director

Mr. John M. Steitz is Independent Director of Innophos Holdings, Inc., since February 2009. He was the Chief Executive Officer of Addivant Corporationrationration, a leading global supplier of antioxidants, intermediates, inhibitors, modifiers, UV stabilizers and other additives to the plastic and rubber industries, since March 2015. Before joining Addivant, Mr. Steitz served as President and Chief Operating Officer of PQ Corporationrationration, a leading worldwide producer of specialty inorganic performance chemicals and catalysts, from October 2013. Prior to joining PQ Corporationrationration, he served as President and Chief Executive Officer of Avantor Performance Materials from August 2012 and, prior to that time, as President and Chief Operating Officer of Albemarle Corporationrationration, a leading global developer, manufacturer, and marketer of highlyengineered specialty chemicals. Before joining Albemarle, Mr. Steitz spent twenty years at Mallinckrodt, Inc., holding a variety of positions of increasing responsibility. He eventually served as vice president and general manager of Mallinckrodts pharmaceutical chemicals division. Since February 2017, Mr. Steitz has served as a director of Tredegar Corporationrationration, a publiclytraded manufacturer of plastic films and aluminum extrusions since 2009.
Age 59
Tenure 15 years
Professional MarksMBA
Phone609 495-2495
Webwww.innophos.com
Steitz holds a BS degree in Chemical Engineering from the University of Missouri and an MBA from the Southern Illinois University.

John Steitz Latest Insider Activity

Tracking and analyzing the buying and selling activities of John Steitz against Innophos Holdings stock is an integral part of due diligence when investing in Innophos Holdings. John Steitz insider activity provides valuable insight into whether Innophos Holdings is net buyers or sellers over its current business cycle. Note, Innophos Holdings insiders must abide by specific rules, including filing SEC forms every time they buy or sell Innophos Holdings'shares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.

Innophos Holdings Management Efficiency

Innophos Holdings' management efficiency ratios could be used to measure how well Innophos Holdings manages its routine affairs as well as how well it operates its assets and liabilities.
The company currently holds 399.86 M in liabilities with Debt to Equity (D/E) ratio of 118.3, indicating the company may have difficulties to generate enough cash to satisfy its financial obligations. Innophos Holdings has a current ratio of 2.88, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Innophos Holdings until it has trouble settling it off, either with new capital or with free cash flow. So, Innophos Holdings' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Innophos Holdings sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Innophos to invest in growth at high rates of return. When we think about Innophos Holdings' use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

DIRECTOR Age

Horacio ScapparoneSpirit Airlines
63
Ronald MittelstaedtSkyWest
54
Lawrence EllisonTesla Inc
73
Linda RiceTesla Inc
60
Steve AlbrechtSkyWest
71
Carlton DonawaySpirit Airlines
68
James WelchSkyWest
63
Henry MeyerUnited Airlines Holdings
64
Kimbal MuskTesla Inc
45
James HeppnerUnited Airlines Holdings
60
James KennedyUnited Airlines Holdings
64
Meredith MaddenSkyWest
44
Barney HarfordUnited Airlines Holdings
43
William NutiUnited Airlines Holdings
53
Michele HooperUnited Airlines Holdings
66
Meredith SiegfriedSkyWest
40
Edward ShapiroUnited Airlines Holdings
53
Antonio GraciasTesla Inc
47
John WalkerUnited Airlines Holdings
57
Walter IsaacsonUnited Airlines Holdings
65
Robert JohnsonSpirit Airlines
73
Innophos Holdings, Inc., together with its subsidiaries, produces specialty ingredients with applications in food, health, nutrition, and industrial markets. As of February 7, 2020, Innophos Holdings, Inc. operates as a subsidiary of Iris Parent LLC. Innophos Holdings operates under Specialty Chemicals classification in USA and is traded on NASDAQ. It employs 1485 people. Innophos Holdings (IPHS) is traded on NASDAQ Exchange in USA and employs 1,485 people.

Management Performance

Innophos Holdings Leadership Team

Elected by the shareholders, the Innophos Holdings' board of directors comprises two types of representatives: Innophos Holdings inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Innophos. The board's role is to monitor Innophos Holdings' management team and ensure that shareholders' interests are well served. Innophos Holdings' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Innophos Holdings' outside directors are responsible for providing unbiased perspectives on the board's policies.
Randolph Gress, Chairman, CEO and Pres
Eugenia Erlij, Vice President - Marketing
Kim Mink, CEO and President and Director
Abraham Shabot, Vice President Director General, Innophos Latin America
James Zallie, Independent Director
Peter Thomas, Director
Jean Mainente, Chief Human Resource Officer, Senior Vice President
William Dunworth, Chief Accounting Officer, Vice President Corporate Controller
Amado Cavazos, Independent Director
Nicolas Meyrial, Vice President - Commercial Nutrition
William Farran, Sr. VP, General Counsel and Member of Proxy Committee
Mark Thurston, Vice President - Corporate Strategy and Worldwide Business Development
Mark Feuerbach, Sr. VP of Investor Relations, Treasury, Financial Planning and Analysis
Mark Santangelo, Senior Vice President - Manufacturing, Engineering and EH&S
Gary Cappeline, Lead Independent Director
Susan Turner, Vice President - Quality & Regulatory
Yasef Murat, Senior Vice President - Global Manufacturing
Hermanus Kieftenbeld, CFO, Senior Vice President
Linda Myrick, Independent Director
Amy Hartzell, Vice President - Supply Chain and Purchasing
Sherry Duff, Chief Marketing Officer, Vice President
Gail Holler, Vice President - Human Resources
Joshua Horenstein, Acting Chief Legal Officer and Corporate Secretary
Jane Hilk, Director
Louis Calvarin, Chief Risk Officer and Sr. VP of Strategy
Robert Sklans, Chief Human Resource Officer, Senior Vice President
Joseph Golowski, Sr. VP of Global Specialty Phosphates
Charles Brodheim, Vice President Corporate Controller
Karen Osar, Independent Director
John Steitz, Independent Director
Robert Zatta, Director

Innophos Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Innophos Holdings a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in rate.
Note that the Innophos Holdings information on this page should be used as a complementary analysis to other Innophos Holdings' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.

Other Consideration for investing in Innophos Stock

If you are still planning to invest in Innophos Holdings check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Innophos Holdings' history and understand the potential risks before investing.
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Commodity Directory
Find actively traded commodities issued by global exchanges
Stocks Directory
Find actively traded stocks across global markets
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account